Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alcon Breaks Ground On Singapore Plant To Make Eye-care Drugs

This article was originally published in PharmAsia News

Executive Summary

Alcon, a Switzerland-based maker of eye-care products, has begun construction of its first Asian production plant in Singapore. Alcon said the plant was needed because of the company's growth in Asia, for making drugs to treat eye disorders such as glaucoma. Alcon said it expects to complete construction in 2012, when it expects to create 150 new jobs. Novartis AG, another Swiss drug maker, plans to buy a 77 percent interest in Alcon, beyond its existing 25 percent stake. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts